Our Global Head of Quality, Suzanne Ivory breaks down everything you need to consider when deciding to build or buy an Artwork Management System (AMS) in our comprehensive article.
We’ve been looking at some of the possible outcomes of Brexit for the Life Science Industry and specifically, what effect it could have on artwork. Our regulatory experts have put together this overview of the challenges and solutions to the Brexit conundrum.
If you are looking for fully compliant and error-free pharma artworks to hit the market efficiently while reducing your stress levels, keep an eye on the following four most common pharma artwork hurdles.
The GLAMS Business Intelligence and enhanced KPI Reporting feature provides configurable dashboards allowing faster analysis and reporting.
Perigord explains the importance of compliant, validated labelling and artwork solutions in the pharmaceutical sector and is offering the solutions to optimise your end-to-end artwork process.
According to recent research, the global pharmaceutical packaging market is forecasted to reach more than US$80 billion in revenue by 2020.
Risk in the Life Sciences industry is inevitable. It’s not a matter of if your company is going to manage it, it’s a matter of how, and more importantly, how well.
The ability to manage the pharma supply chain on a global level can provide CMOs with a crucial competitive advantage. GLAMS CMO is the key to taking control of the labelling and artwork process.